Figure 6.
P2Y1 Receptor blockade or NM23 antagonist significantly suppresses tumor formation in vivo. In separate experiments conducted as described for the images seen in figure 5, with 6 animals/group, the effect of endostatin, EA, MRS2179 or the combination on tumor volume over time was determined. Inset: comparison of control data versus endostatin treatment.